Cagrilintide is a long-acting amylin analog peptide, studied in metabolic research. It is supplied for research use only and is sometimes studied alongside GLP-1 peptides.
What Cagrilintide is
Cagrilintide is a synthetic analog of amylin, a naturally occurring peptide involved in metabolic signaling. It is designed to be long-acting, which is part of why it draws research interest.
How it is studied
In the laboratory, Cagrilintide is studied in metabolic research, sometimes in combination with GLP-1 compounds such as Semaglutide. As with any research peptide, it is a study tool and is not approved or intended for human use.
Browse research-grade peptides
Every Axis compound is third-party tested to 99.4%+ purity, with a certificate of analysis on every batch.
What to look for
A research-grade Cagrilintide should ship with a batch-specific certificate of analysis. For a comparison, see Cagrilintide vs. Semaglutide.
Key takeaways
- Cagrilintide is a long-acting amylin analog peptide.
- It is studied in metabolic research.
- It is a different class from GLP-1, but often studied alongside it.
- Research-grade Cagrilintide is supplied for research use only.
A note on research use
The peptides supplied by Axis Peptide Labs are reference compounds for laboratory and research use only. They are intended for qualified researchers working in academic, institutional, and analytical settings. They are not drugs, foods, cosmetics, or medical products, and they are not intended for human or veterinary consumption. Documented identity and documented purity are what matter most when sourcing a compound, both of which are published on the Axis certificates of analysis page.
